IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MJ who wrote (159)	11/14/1997 12:43:00 AM
From: Druss	of 1510

MJ--Here is a paragraph from a company press release of Sept 22. The Immune Response Corporation has numerous clinical trials of REMUNE underway including a Phase III clinical endpoint study involving 2,500 patients; a Phase II combination drug trial being conducted in conjunction with Glaxo Wellcome, plc and Merck & Co., additional Phase II trials in Thailand and Spain; and a Phase I trial in children at the National Institutes of Health. Hope this helps. All the Best Druss

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next